BridgeBio Pharma, Inc.
Ticker: 1743881
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 194.52+61.2% | 120.70+9.2% | 110.57-5.2% | 116.63+4172.2% | 2.73+25.8% | 2.17-99.0% | 211.12+5061.9% | 4.09 |
| Total Income | 194.52+61.2% | 120.70+9.2% | 110.57-5.2% | 116.63+4172.2% | 2.73+25.8% | 2.17-99.0% | 211.12+5061.9% | 4.09 |
| EXPENSES | ||||||||
| Expenditure | 300.47+13.0% | 265.90+8.6% | 244.84+10.8% | 221.01+13.6% | 194.48+9.4% | 177.71-15.7% | 210.78+30.3% | 161.78 |
| Tax | — | -1.55-173.8% | 2.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | — | -186.48-2.7% | -181.66 | — | — | — | — | — |
| Net Profit | -164.04+10.2% | -182.74-0.5% | -181.90-8.6% | -167.42-3.3% | -162.04-120.6% | -73.46-108.6% | -35.22+80.1% | -177.00 |
| KEY METRICS | ||||||||
| OPM % | -54.47%+45.53pp | -100.00% | -100.00%-10.51pp | -89.49%+10.51pp | -100.00% | -100.00%-100.16pp | 0.16%+100.16pp | -100.00% |
| NPM % | -84.33%+15.66pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-83.32pp | -16.68%+83.32pp | -100.00% |
| EPS | -0.84+11.6% | -0.95+0.0% | -0.95-8.0% | -0.88-2.3% | -0.86-120.5% | -0.39-95.0% | -0.20+81.5% | -1.08 |
Corporate Events
Board MeetingBBIO
202622Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, approve e…
SEC Filing ↗